Makhteshim Agan CEO Resigns
9 January 2014 
Vigodman
Photo courtesy Makhteshim Agan
Makhteshim Agan said its president and chief executive officer, Erez Vigodman, has stepped down to join Israel’s Teva Pharmaceuticals as president and CEO.
MAI’s board expects to name his permanent replacement “over the next few weeks.”
Vigodman will continue to serve in his position until early February 2014, by which time a replacement will be named, MAI said.
MAI Chairman Yang Xingqiang said: “On behalf of the Board, I would like to extend our deep appreciation to Erez for his years of dedicated service to the company. Under his direction, MAI’s senior management team successfully strengthened the organizational culture and reinforced its employee sense of pride. The team implemented a strategic and operational transformation, which contributed to financial growth and improvement, and enhanced the company’s competitive position.”
Xingqiang continued, “In his tenure, MAI completed the merger with ChemChina, created a stronger operating platform, solidified R&D capabilities, successfully broadened, and differentiated its product portfolio. Thanks in large measure to his strong leadership and personal spirit, MAI today is positioned for continued success with a well-articulated strategic vision, a strong senior management team, and an inspired employee base. We wish him much success in his new position at Teva. The Board is committed to the continued growth and success of MAI and expects to name a replacement as soon as possible.”
Vigodman commented, “I am grateful for having had the opportunity to work with MAI’s thousands of talented and passionate employees worldwide and extraordinary management team. Together, we have worked to build a remarkable, industry-leading company of which we can all be extremely proud. MAI’s unique values and culture truly stand out and make this organization special.”
Get The Newsletter Today!
